In the high-stakes world of tech and life sciences, where you get your money is often as important as how much you raise. The source of your funding doesn’t just provide a balance sheet; it brings with it a specific set of legal obligations, governance expectations, and exit pressures that can either accelerate your vision or fundamentally compromise it.
Many founders treat fundraising as a desperate search for any available cash. However, a “check is not just a check.” An investor who isn’t aligned with your industry’s regulatory timelines or your personal exit goals can become a “toxic” presence on your cap table, complicating future rounds and deterring top-tier institutional VCs.
Crowley Law helps founders navigate the diverse landscape of capital sources. We provide more than just document review; we offer the strategic legal foresight needed to ensure that your choice of funding today doesn’t create a legal or structural bottleneck tomorrow.
In the startup world, the wrong investor can erode control, slow growth, or limit your exit, so choosing the right funding source demands a rigorous assessment of your stage, sector, capital needs, and long-term goals.
Our approach focuses on aligning capital with corporate strategy. These are the steps to take:
In the startup ecosystem, “bad money” is the most expensive mistake you can make. If you take capital from an investor who doesn’t understand your industry’s “valleys of death,” you risk losing control when you need it most. A strategic funding plan allows you to maintain leverage.
Crowley Law acts as your legal architect, ensuring that whether you are bootstrapping or closing a Series A, your corporate structure remains “clean” and attractive to future partners.
A balanced approach to capitalization offers several competitive advantages:
Each agreement serves a different protective function, and using the wrong tool can leave your startup vulnerable.
Source | Primary Function | Key Risk | Best For |
Bootstrapping | Self-funding via personal savings or early revenue. | Slow growth and high personal financial exposure. | Early validation and maintaining 100% control. |
Angel Investors | High-net-worth individuals providing early “seed” capital. | Individual “whims” and limited follow-on capacity. | Moving from prototype to initial market traction. |
Venture Capital (VC) | Institutional funds for rapid, proactive scaling. | High dilution and significant loss of board control. | High-growth companies with massive market potential. |
Government Grants | Non-dilutive capital for specific R&D or social goals. | Rigid reporting and slow disbursement timelines. | Deep tech and Life Sciences in the pre-clinical stage. |
Each funding source looks at your “legal health” through a different lens. Gaps in your foundation can cause a “pass” from a VC or a failed audit for a grant.
Crowley Law focuses on these essential preparatory elements:
The “market standard” for a term sheet varies wildly depending on who is sitting across the table. We support you through:
Successful fundraising goes beyond the numbers; it requires understanding the psychological and legal profile of the entity providing the capital. Negotiating with a seasoned Venture Capitalist requires a different tactical approach than aligning with a Corporate Strategic partner.
At Crowley Law, we help you prepare for these specific interactions:
We are not just legal representatives, we are your strategic partners. We help you understand not just the terms, but the intent behind the capital.
Crowley Law LLC combines decades of corporate legal experience with personalized counsel tailored to the unique needs of startups. The firm is led by Philip P. Crowley, with over 45 years of experience, including prior service as corporate counsel at Johnson & Johnson, where he managed complex internal governance and licensing matters.
Crowley Law focuses on providing strategic, practical advice that helps founders and partners build strong structures, resolve conflicts, and navigate growth smoothly.
Map your funding options strategically, with legal protection that safeguards your vision and preserves your equity.
Usually, yes, but it often comes with “time dilution.” The administrative burden of grants can distract you from building your product.
Absolutely. In fact, VCs often prefer founders who have “de-risked” the company using their own resources first.
A company (like a large pharma or tech giant) that invests in you because your technology helps their core business.
If you have dozens of unaccredited investors, missing IP assignments, or complicated “notes” with no caps, your cap table likely needs a legal cleanup.
Sources like VC usually demand board seats and veto rights on major decisions, whereas Angels and Bootstrapping typically allow you to maintain more day-to-day autonomy.
